ArticleArchives of toxicology2026
ChemSkin DB 2.0: a comprehensive reference chemical database for skin corrosion and irritation.
Article in Archives of toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
We previously developed ChemSkin DB listing 100 reference chemicals to aid the development of new approach methodologies (NAMs) for skin irritation. However, ChemSkin DB is insufficient for NAMs addressing the full spectrum of skin hazards, i.e., skin corrosion and irritation. To address this gap, ChemSkin DB was expanded with 134 reference chemicals to ChemSkin DB 2.0 as a harmonized reference database aligning skin corrosion and irritation data with UN GHS criteria. A total of 234 unique substances were consolidated and assigned to reference categories under a precautionary decision framework. ChemSkin DB 2.0 contains normalized in vivo metrics and model-specific in vitro viability values obtained with OECD TG 431 and 439 In Vitro Skin Corrosion and Irritation Tests: Reconstructed Human Epidermis (RhE) Test Methods, ensuring transparency and regulatory traceability. Especially, performance evaluation demonstrated substantial agreement across OECD TG 431 RhE models for corrosion identification. In contrast, OECD TG 439 irritation RhE models showed moderate to substantial agreement, with variability in specificity linked to the single-threshold structure of irritation classification. Chemical category stratification further revealed chemical class-dependent performance patterns across both endpoints, highlighting the influence of mechanistic diversity on model reliability. Collectively, ChemSkin DB 2.0 provides a severity-stratified, regulatory-aligned reference resource that supports transparent model development and evaluation, and improved consistency in skin hazard assessment.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.